Jayasree K. Iyer to speak at The Economist Antimicrobial Resistance Summit

In a classic market failure, ageing antibiotics that are no longer effective are not being replaced by new ones. The traditional model of volume-based reimbursement is failing and antibiotic pipelines remain weak. 

Jayasree will join a panel titled 'The (private sector) investment conundrum' where she will discuss why pharma companies are no longer investing in developing new antibiotics, which of the incentives designed to reward successful antibiotic R&D shows the most potential, and how they can be made to work. 

Little progress has been made since the special declaration on antimicrobial resistance (AMR) at the UN General Assembly in September 2016. Yet the risk of returning to a pre-antibiotic era remains real. This event, organised by The Economist, will bring together over 120 health policy leaders, academics and industry experts to discuss how to galvanise support for the global fight against AMR.